Translocation carcinomas of the kidney

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Renal cell carcinomas (RCCs) in pediatric and young adult populations often exhibit unique chromosomal translocations.
• These translocations lead to the formation of gene fusions involving the MiTF/TFE transcription factor family.

Purpose of the Study:

• To investigate the role of specific chromosome translocations in pediatric and young adult RCCs.
• To evaluate the utility of immunohistochemistry for TFE3 and TFEB as diagnostic markers for translocation-associated RCCs.

Main Methods:

• Analysis of chromosomal translocations in pediatric and young adult RCCs.
• Identification of gene fusions involving the MiTF/TFE family.
• Immunohistochemical staining for TFE3 and TFEB expression in tumor tissues.

Main Results:

• Xp11-translocation carcinomas are characterized by TFE3 gene fusions.
• Renal carcinomas with t(6;11)(p21;q12) exhibit an Alpha-TFEB gene fusion.
• Nuclear TFE3 or TFEB labeling by immunohistochemistry serves as a sensitive and specific marker for these RCC subtypes.

Conclusions:

• Specific gene fusions driven by chromosomal translocations are key oncogenic events in a subset of pediatric and young adult RCCs.
• Immunohistochemistry for TFE3 and TFEB is a valuable diagnostic tool for identifying these specific RCC types.
• Further research is needed to determine the clinical behavior of these neoplasms compared to conventional adult-type RCCs.